Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment

Citation
K. Yeboah-antwi et al., Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment, B WHO, 79(5), 2001, pp. 394-399
Citations number
26
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
Journal title
BULLETIN OF THE WORLD HEALTH ORGANIZATION
ISSN journal
00429686 → ACNP
Volume
79
Issue
5
Year of publication
2001
Pages
394 - 399
Database
ISI
SICI code
0042-9686(2001)79:5<394:IOPADO>2.0.ZU;2-L
Abstract
Objective To examine the extent to which district health teams could reduce the burden of malaria, a continuing major cause of mortality and morbidity , in a situation where severe resource constraints existed and integrated c are was provided. Methods Antimalarial drugs were prepackaged into unit doses in an attempt t o improve compliance with full courses of chemotherapy. Findings Compliance improved by approximately 20% in both adults and childr en. There were 50% reductions in cost to patients, waiting time at dispensa ries and drug wastage at facilities. The intervention, which tended to impr ove both case and drug management at facilities, was well accepted by healt h staff and did not involve them in additional working time. Conclusion The prepackaging of antimatarials at the district level offers t he prospect of improved compliance and a reduction in the spread of resista nce.